Informed Girl
Informed SkinRestylane Lyft

Dermal Fillers

Restylane Lyft

Hyaluronic Acid Filler (NASHA)

Larger-particle HA filler for cheeks, nasolabial folds, and hands

Volume LossCrepey Neck
In plain English

Restylane Lyft is a gel filler injected into the cheeks, the folds beside the nose, or the backs of the hands to restore volume that's been lost over time. It's slightly softer than some competing products, which gives a natural-feeling result rather than a very structured lift. It's FDA-approved specifically for the cheeks and hands, which is relatively uncommon in this product category.

Safe for skin types
Safe forAll Fitzpatrick types I–VI
Avoid ifActive skin infection at injection site; known HA allergy; pregnancy

Hyaluronic acid fillers are not affected by skin tone. Bruising and swelling appear the same across skin types. Vascular occlusion risk is equal across all types.

Common misconceptions
Myth

Restylane and Juvederm products are interchangeable

Reality

They use different cross-linking technologies (NASHA vs. Vycross) with meaningfully different rheological properties. Swelling behaviour, longevity, and tissue integration all differ. Substituting between product ranges without adjusting technique and volume expectation is not appropriate.

Myth

HA filler is safe because it is naturally occurring

Reality

Commercial HA fillers are chemically cross-linked, not naturally occurring in that form. Vascular occlusion, DIR, biofilm formation, and Tyndall effect are all genuine documented risks. The substrate being biocompatible does not eliminate the technique-dependent and material-specific risks.

Quick Facts
Duration9–12 months
Studies1,100+
FDA StatusFDA Approved (2015)
Price$650–$1,100/syringe

Should You Try This?

15107OUT OF 10

Probably okay to try

Educational content only. This page summarises published clinical research and is not medical advice. Consult a qualified healthcare provider before making decisions about your care.

Researched by

Val Yermakova

Informed Girl · informedgirl.com

The Weekly Briefing

Stay informed

Every paper is individually reviewed and scored for study design, blinding, and funding independence. Educational content, not medical advice.

Subscribe for updates about the latest research. No spam.